If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "Imaginostics Software Suite"
Landonodnal (talk | contribs) (Created page with "Category:Software "Our breakthrough platform imaging technology transforms any clinical scanner into powerful quantitative diagnostic tools by acquiring a quantitative sig...") |
Landonodnal (talk | contribs) |
||
| Line 3: | Line 3: | ||
Clinicians and scientists are using our software that provides a quantitative signal in conjunction with safe iron-oxide based contrast agents to selectively enhance the vascular compartment. Our platform technology has many more potential uses, such as safe vascular visualization for renal patients, quantitative characterization of chronic diseases, and acute point-of-care diagnostics for traumatic brain injury or stroke." | Clinicians and scientists are using our software that provides a quantitative signal in conjunction with safe iron-oxide based contrast agents to selectively enhance the vascular compartment. Our platform technology has many more potential uses, such as safe vascular visualization for renal patients, quantitative characterization of chronic diseases, and acute point-of-care diagnostics for traumatic brain injury or stroke." | ||
| + | |||
| + | ==Organizations== | ||
| + | *[[Imaginostics|Imaginostics]] | ||
==Links== | ==Links== | ||
[https://imaginostics.com/technology/ Website] | [https://imaginostics.com/technology/ Website] | ||
Latest revision as of 01:37, 6 April 2022
"Our breakthrough platform imaging technology transforms any clinical scanner into powerful quantitative diagnostic tools by acquiring a quantitative signal intensity without the need for a baseline. Until now, MRI signal intensity has been only semi-quantitative because of sensitivity to susceptibility, vessel orientations and tortuosity, blood flow, blood volume and oxygenated state of hemoglobin.
Clinicians and scientists are using our software that provides a quantitative signal in conjunction with safe iron-oxide based contrast agents to selectively enhance the vascular compartment. Our platform technology has many more potential uses, such as safe vascular visualization for renal patients, quantitative characterization of chronic diseases, and acute point-of-care diagnostics for traumatic brain injury or stroke."